• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与植入式心脏复律除颤器接受度相关的患者相关因素的定性分析

A Qualitative Analysis of Patient-Related Factors Associated With Implantable Cardioverter Defibrillator Acceptance.

作者信息

Johnson Amber E, Bell Yamira K, Hamm Megan E, Saba Samir F, Myaskovsky Larissa

机构信息

Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA.

School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.

出版信息

Cardiol Ther. 2020 Dec;9(2):421-432. doi: 10.1007/s40119-020-00180-9. Epub 2020 May 31.

DOI:10.1007/s40119-020-00180-9
PMID:32476091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7584700/
Abstract

INTRODUCTION

Patient-related factors determining implantable cardioverter-defibrillator (ICD) use for primary prevention of sudden cardiac death in patients with cardiomyopathy have not been well explored. To assess race and sex differences regarding ICD preferences in this patient population, we sought to analyze a diverse cohort of patients with heart failure (HF) with reduced ejection fraction.

METHODS

We conducted qualitative interviews of 28 adults with severe HF and either (1) an ICD or (2) no ICD. Interviews were recorded, transcribed, and coded using an inductively developed codebook by independent investigators. Coding was fully adjudicated and transcripts were reviewed to identify themes.

RESULTS

We recruited patients between 12/2015 and 06/2017, primarily from the outpatient cardiology clinic (24/28 = 86%). Half were women (50%) and 13/28 (46%) were black. Eight did not have an ICD. Neither race nor sex was associated with ICD. Four themes emerged: (1) HF requiring an ICD is profoundly disruptive to patients' lives; (2) patients had positive, yet unrealistic opinions of ICDs; or (3) Patients had negative/ambivalent opinions of ICDs; (4) medical decision-making included aspects of shared decision-making and informed consent.

CONCLUSIONS

Patients without ICDs perceived less benefit from ICDs and had less decision support. Participants viewed conversations with providers as insufficient. Needed interventions include the development and validation of processes for informed decisions about ICDs.

摘要

引言

在心肌病患者中,决定使用植入式心脏复律除颤器(ICD)进行心脏性猝死一级预防的患者相关因素尚未得到充分研究。为了评估该患者群体在ICD偏好方面的种族和性别差异,我们试图分析一组射血分数降低的心力衰竭(HF)患者。

方法

我们对28名患有严重HF的成年人进行了定性访谈,这些患者要么(1)植入了ICD,要么(2)未植入ICD。访谈由独立调查人员进行记录、转录,并使用归纳开发的编码手册进行编码。编码经过全面裁决,并对转录本进行审查以确定主题。

结果

我们在2015年12月至2017年6月期间招募患者,主要来自门诊心脏病诊所(24/28 = 86%)。一半为女性(50%),13/28(46%)为黑人。8名患者未植入ICD。种族和性别均与ICD无关。出现了四个主题:(1)需要植入ICD的HF对患者生活造成极大干扰;(2)患者对ICD有积极但不切实际的看法;(3)患者对ICD有消极/矛盾的看法;(4)医疗决策包括共同决策和知情同意的方面。

结论

未植入ICD的患者认为ICD带来的益处较少,且决策支持较少。参与者认为与医疗服务提供者的沟通不足。所需的干预措施包括开发和验证关于ICD的知情决策流程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d446/7584700/dcfe4f736035/40119_2020_180_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d446/7584700/dcfe4f736035/40119_2020_180_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d446/7584700/dcfe4f736035/40119_2020_180_Fig1_HTML.jpg

相似文献

1
A Qualitative Analysis of Patient-Related Factors Associated With Implantable Cardioverter Defibrillator Acceptance.与植入式心脏复律除颤器接受度相关的患者相关因素的定性分析
Cardiol Ther. 2020 Dec;9(2):421-432. doi: 10.1007/s40119-020-00180-9. Epub 2020 May 31.
2
Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.植入式心脏复律除颤器。预防性应用:基于证据的分析。
Ont Health Technol Assess Ser. 2005;5(14):1-74. Epub 2005 Sep 1.
3
Assisting Black Patients With Decision-Making for Implantable Cardioverter Defibrillator Therapy: Qualitative Findings From the Videos to Reduce Racial Disparities in ICD Therapy via Innovative Designs (VIVID) Trial.协助黑人患者决策植入式心脏复律除颤器治疗:通过创新设计降低 ICD 治疗种族差异的视频减少种族差异试验(VIVID)的定性发现。
Circ Cardiovasc Qual Outcomes. 2024 Jul;17(7):e010550. doi: 10.1161/CIRCOUTCOMES.123.010550. Epub 2024 Jun 12.
4
Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.用于治疗心律失常的植入式心脏复律除颤器和用于治疗心力衰竭的心脏再同步治疗:系统评价与经济学评估
Health Technol Assess. 2014 Aug;18(56):1-560. doi: 10.3310/hta18560.
5
6
Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy.用于非缺血性心肌病患者的植入式心脏除颤器。
Cochrane Database Syst Rev. 2018 Dec 8;12(12):CD012738. doi: 10.1002/14651858.CD012738.pub2.
7
Patients' Perspectives Regarding Generator Exchanges of Implantable Cardioverter Defibrillators.患者对植入式心脏复律除颤器的发电机更换的看法。
Circ Cardiovasc Qual Outcomes. 2023 Aug;16(8):509-518. doi: 10.1161/CIRCOUTCOMES.122.009827. Epub 2023 Jul 26.
8
Patients' decision making to accept or decline an implantable cardioverter defibrillator for primary prevention of sudden cardiac death.患者决定是否接受植入式心脏复律除颤器预防原发性心搏骤停。
Health Expect. 2013 Mar;16(1):69-79. doi: 10.1111/j.1369-7625.2011.00703.x. Epub 2011 Jun 7.
9
Decision-Making of Patients With Implantable Cardioverter-Defibrillators at End of Life: Family Members' Experiences.植入式心脏复律除颤器患者临终时的决策制定:家庭成员的经历
Am J Hosp Palliat Care. 2017 Jul;34(6):518-523. doi: 10.1177/1049909116641622. Epub 2016 Mar 31.
10
Patient barriers to implantable cardioverter defibrillator implantation for the primary prevention of sudden cardiac death in patients with heart failure and reduced ejection fraction.心力衰竭且射血分数降低患者植入式心脏复律除颤器植入用于心脏性猝死一级预防的患者障碍。
Singapore Med J. 2016 Apr;57(4):182-7. doi: 10.11622/smedj.2016072.

引用本文的文献

1
Sex-related similarities and differences in responses to heart failure therapies.性别相关的心力衰竭治疗反应的相似性和差异性。
Nat Rev Cardiol. 2024 Jul;21(7):498-516. doi: 10.1038/s41569-024-00996-1. Epub 2024 Mar 8.
2
The effect of virtual interactive nurse-led support group intervention on fatigue, shock anxiety, and acceptance of implantable cardioverter defibrillator patients: a randomized trial.虚拟互动护士主导的支持小组干预对植入式心脏复律除颤器患者疲劳、休克焦虑和接受程度的影响:一项随机试验。
BMC Cardiovasc Disord. 2024 Jan 11;24(1):40. doi: 10.1186/s12872-024-03713-5.
3
Using Patient Decision Aids for Cardiology Care in Diverse Populations.

本文引用的文献

1
Persistent sex disparities in implantable cardioverter-defibrillator therapy.植入式心脏复律除颤器治疗中持续存在的性别差异。
Pacing Clin Electrophysiol. 2018 Sep;41(9):1150-1157. doi: 10.1111/pace.13435. Epub 2018 Jul 19.
2
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.2017年美国心脏协会/美国心脏病学会/心律学会室性心律失常患者管理和心脏性猝死预防指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南工作组和心律学会的报告
Circulation. 2018 Sep 25;138(13):e210-e271. doi: 10.1161/CIR.0000000000000548.
3
在不同人群的心脏科护理中使用患者决策辅助工具。
Curr Cardiol Rep. 2023 Nov;25(11):1543-1553. doi: 10.1007/s11886-023-01953-z. Epub 2023 Nov 9.
4
A qualitative crossroads of rhythm and race: Black patients' experiences living with atrial fibrillation.节奏与种族的质性交叉点:黑人房颤患者的生活经历
Am Heart J Plus. 2023 Apr;28. doi: 10.1016/j.ahjo.2023.100293. Epub 2023 Mar 29.
5
[Between trivialization and pathologization: Healthcare in old age and the temporal structure of a good life].[在轻视与病态化之间:老年保健与美好生活的时间结构]
Ethik Med. 2023;35(1):77-91. doi: 10.1007/s00481-022-00742-6. Epub 2023 Jan 4.
6
Impact of an Automated Best Practice Alert on Sex and Race Disparities in Implantable Cardioverter-Defibrillator Therapy.自动最佳实践警报对植入式心脏复律除颤器治疗中性别和种族差异的影响。
J Am Heart Assoc. 2022 Apr 5;11(7):e023669. doi: 10.1161/JAHA.121.023669. Epub 2022 Mar 18.
Utilization of cardiac resynchronization therapy in eligible patients hospitalized for heart failure and its association with patient outcomes.心力衰竭住院合格患者心脏再同步治疗的应用及其与患者预后的关联。
Am Heart J. 2017 Jul;189:48-58. doi: 10.1016/j.ahj.2017.04.001. Epub 2017 Apr 6.
4
Evidence of Cognitive Bias in Decision Making Around Implantable-Cardioverter Defibrillators: A Qualitative Framework Analysis.关于植入式心脏除颤器决策的认知偏差的证据:定性框架分析。
J Card Fail. 2017 Nov;23(11):794-799. doi: 10.1016/j.cardfail.2017.03.008. Epub 2017 Mar 28.
5
Underutilization of Implantable Cardioverter Defibrillator in Primary Prevention of Sudden Cardiac Arrest.植入式心脏复律除颤器在心脏性猝死一级预防中的应用不足
Cardiol Res. 2011 Feb;2(1):1-6. doi: 10.4021/cr13w. Epub 2011 Jan 20.
6
Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Myocardial Infarction.心肌梗死后射血分数降低的 Medicare 患者中心脏功能和植入式心脏复律除颤器使用的再评估。
Circulation. 2017 Jan 3;135(1):38-47. doi: 10.1161/CIRCULATIONAHA.116.022359. Epub 2016 Nov 16.
7
Decision-Making Experiences of Patients with Implantable Cardioverter Defibrillators.植入式心脏复律除颤器患者的决策经历
Pacing Clin Electrophysiol. 2016 Oct;39(10):1061-1069. doi: 10.1111/pace.12943. Epub 2016 Sep 22.
8
Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings from the Get With The Guidelines-Heart Failure Program.心力衰竭住院患者植入式心脏复律除颤器咨询与使用中的性别及种族/民族差异:来自“遵循指南-心力衰竭”项目的发现
Circulation. 2016 Aug 16;134(7):517-26. doi: 10.1161/CIRCULATIONAHA.115.021048. Epub 2016 Aug 4.
9
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南:欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗工作组编写,欧洲心脏病学会心力衰竭协会(HFA)提供特别贡献。
Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20.
10
Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association.执行摘要:《2016年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2016 Jan 26;133(4):447-54. doi: 10.1161/CIR.0000000000000366.